MPI Kolloquiumsreihe: Life Cycle of Artemisinin: from extraction to derivatisation and drug activity

The talk will discuss issues around production of sufficient quantity and quality of artemisinin drug precursor based on conventional farming-extraction route, but focusing on environmentally-friendly solvents and processes. Conversion of artemisinin drug precursor into APIs using intensified continuous process will be briefly discussed as a potential approach to reducing the cost of the artemisinin-based drugs. The final approach to reducing the cost of drugs is modulating activity of API with other natural substances which possess synergistic interaction with artemisinins, increasing their potency.